GlobeNewswire 6/10/2025 Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Tr...
GlobeNewswire 6/5/2025 Diginex Limited Signs MOU to Acquire Resulticks for US$2bn, transforming AI and Data Management Capa...
GlobeNewswire 6/4/2025 ROHM Develops Breakthrough AI-Equipped MCU
GlobeNewswire 5/20/2025 EverCommerce Appoints Amy Guggenheim Shenkan to Its Board of Directors
GlobeNewswire 5/15/2025 Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Bu...
GlobeNewswire 5/14/2025 BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Par...
GlobeNewswire 5/7/2025 BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congre...
GlobeNewswire 5/5/2025 BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Maste...
GlobeNewswire 5/5/2025 Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Inject...
GlobeNewswire 4/22/2025 Zurab Tsereteli, Internationally Acclaimed Artist and Friend of Wolf Popper LLP, Dies at 91
GlobeNewswire 4/16/2025 BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with Fi...
GlobeNewswire 4/15/2025 Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire 4/15/2025 Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Ph...
GlobeNewswire 4/1/2025 REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire 4/1/2025 Sky Quarry Reports 4th Quarter and Fiscal Year 2024 Financial Results
GlobeNewswire 3/31/2025 Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-...
GlobeNewswire 3/25/2025 Comstock Settles Strategic Commitments and Strengthens Balance Sheet
GlobeNewswire 3/19/2025 Comstock Announces 2025 Annual Meeting and Record Date
GlobeNewswire 3/13/2025 Modat launches premier product, Modat Magnify for Cybersecurity Professionals
GlobeNewswire 3/6/2025 Comstock Announces Full Year 2024 Results
GlobeNewswire 2/28/2025 Comstock Fuels Completes Financing with Marathon Petroleum
GlobeNewswire 2/27/2025 Comstock Inc. to Host Q4 Earnings Call and Business Update on March 6th at 4:30pm ET
GlobeNewswire 2/24/2025 Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the...
GlobeNewswire 2/20/2025 Comstock Fuels Expands RenFuel Partnership
GlobeNewswire 2/19/2025 Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate